| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/28/2010 | EP2178881A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 04/28/2010 | EP2178851A1 Compounds and methods for modulating fxr |
| 04/28/2010 | EP2178845A2 Inhibitors of 11b-hydroxysteroid dehydrogenase |
| 04/28/2010 | EP2178546A1 Herbal formulations for controlling blood glucose levels in patients with diabetes |
| 04/28/2010 | EP2178545A2 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same |
| 04/28/2010 | EP2178537A1 Beta carboline derivatives as antidiabetic compounds |
| 04/28/2010 | EP2178525A1 Resveratrol complex and process for the preperation |
| 04/28/2010 | EP2029547B1 Fxr agonists |
| 04/28/2010 | EP1474142B1 Preparations containing folic acid, vitamin b6, and vitamin b12, and use thereof |
| 04/28/2010 | EP1461339B1 Spiroazacyclic compounds as monoamine receptor modulators |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | EP1356067B1 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | EP1261368B1 Crosslinked, non-fungal lipase-containing composition and methods of use thereof |
| 04/28/2010 | EP1062240B1 N-terminally modified glp-1 derivatives |
| 04/28/2010 | EP1060191B1 Derivatives of glp-1 analogs |
| 04/28/2010 | EP1056775B1 Glp-1 derivatives of glp-1 and exendin with protracted profile of action |
| 04/28/2010 | CN1903193B Use of Naka-furan-8-lactone |
| 04/28/2010 | CN1857293B Medicine composition containing wild astragaloside and paeoniforin |
| 04/28/2010 | CN1845749B Use of a single-cell protein material |
| 04/28/2010 | CN1845748B Pharmaceutical use of fish protein hydrolyzate |
| 04/28/2010 | CN1816550B Indolyl derivatives substituted with a thiazole ring and their use as PPAR modulators |
| 04/28/2010 | CN1785253B Micro-balls of compound red-rooted salvia injection, and its preparation method |
| 04/28/2010 | CN1758913B Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 04/28/2010 | CN1758906B Compositions for the improvement of obesity |
| 04/28/2010 | CN1711084B Substituted 4-alkoxyoxazol derivatives as PPAR agonists |
| 04/28/2010 | CN1654041B Application of eagle-tea extract total flavone in preparation of medicine for regulating blood fat |
| 04/28/2010 | CN1620257B Matrix-forming composition containing pectin |
| 04/28/2010 | CN1596266B Specific binding agents of human angiopoietin-2 |
| 04/28/2010 | CN1593461B Manufacture method of nutrient oral liquor of ass hide glue flavone |
| 04/28/2010 | CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine, |
| 04/28/2010 | CN1556705B 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives |
| 04/28/2010 | CN1443085B Method for locating compounds which are suitable for treatment and/or prophylaxis of obesity |
| 04/28/2010 | CN101698681A Chimeric polypeptide with dual-targeting function and applications thereof |
| 04/28/2010 | CN101698103A Medicine composite for treating B type diabetes |
| 04/28/2010 | CN101698099A Traditional Chinese medicine for treating diabetes |
| 04/28/2010 | CN101698056A Capsules for diminishing diabetes and lowering sugar |
| 04/28/2010 | CN101698053A Traditional Chinese medicine composite for treating diabetes and preparation method thereof |
| 04/28/2010 | CN101698032A Method for preparing tablets for treating hyperlipemia and prepared product |
| 04/28/2010 | CN101698028A Fat-reducing and weight-losing composite and preparation method thereof |
| 04/28/2010 | CN101697980A Balance-element health-care capsules |
| 04/28/2010 | CN101697803A Grain coix seed porridge medicated food and preparation method thereof |
| 04/27/2010 | US7705052 Sulfonamide derivatives for the treatment of diabetes |
| 04/27/2010 | US7705020 Benzimidazolone carboxylic acid derivatives |
| 04/27/2010 | US7705015 Substituted pyrroline kinase inhibitors |
| 04/27/2010 | US7704988 N-[3-(4-{(2S,3R)-2-(-(4-{[(2S, 5S, 3R, 4R, 6R)-3,4,5-trihydroxy-6-(hydroxymethyl)perhydro-2H-pyran-2-yl]ethyl-2-yl}phenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-1-yl}phenyl)propyl]-N-methylmethanesulfonamide; anticholesterol agent; low density lipoprotein; treating atherosclerosis |
| 04/27/2010 | US7704979 Materials and methods for the treatment or prevention of obesity |
| 04/27/2010 | US7704975 Modafinil compound and cyclodextrin mixtures |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704526 Sustained release composition for oral administration of drugs |
| 04/27/2010 | US7704523 Microbial cellulose wound dressing for treating chronic wounds |
| 04/27/2010 | CA2574985C Composition comprising theanine |
| 04/27/2010 | CA2574984C Composition comprising theanine |
| 04/27/2010 | CA2542780C Drug and food or drink for improving hyperglycemia |
| 04/27/2010 | CA2462939C Novel derivatives of isoquinoline, process for their preparation and pharmaceutical compositions containing them |
| 04/27/2010 | CA2427482C Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor |
| 04/27/2010 | CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 04/22/2010 | WO2010045656A2 Novel sglt2 inhibitor dosage forms |
| 04/22/2010 | WO2010045623A2 Irvingia gabonensis to treat and prevent metabolic syndrome and reduce total cholesterol, ldl cholesterol, blood glucose, c-reactive protein, and leptin levels and increasing increasing adiponectin levels |
| 04/22/2010 | WO2010045621A2 Methods and compositions using irvingia gabonensis to reduce weight, control obesity, effect adipogenesis, lower ppar-gamma, leptin, g3pdh and triglyc-erides levels and increase adiponectin levels |
| 04/22/2010 | WO2010045563A2 Combination therapies for the treatment of obesity |
| 04/22/2010 | WO2010045558A1 Method of determining a phosphorus binder dosage for a dialysis patient |
| 04/22/2010 | WO2010045529A2 Combination therapies for the treatment of obesity |
| 04/22/2010 | WO2010045522A2 Combination therapies for the treatment of obesity |
| 04/22/2010 | WO2010045417A2 Combination therapies for the treatment of obesity |
| 04/22/2010 | WO2010045416A2 Combination therapies for the treatment of obesity |
| 04/22/2010 | WO2010045374A1 3-hydroquinazolin-4-one derivatives for use as stearoyl coa desaturase inhibitors |
| 04/22/2010 | WO2010045371A1 Pyrido- and pyrimido (1, 2-a) pyrimidine compounds useful as stearoyl coa desaturase inhibitors |
| 04/22/2010 | WO2010045311A1 Methods of using nitrogen-containing heterocycle derivatives |
| 04/22/2010 | WO2010045199A2 Method of modulating ship activity |
| 04/22/2010 | WO2010044885A2 Soluble mtor complexes and modulators thereof |
| 04/22/2010 | WO2010044441A1 Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase |
| 04/22/2010 | WO2010044405A1 Fused-ring derivative and medical application of same |
| 04/22/2010 | WO2010044371A1 Insulin secretion stimulator |
| 04/22/2010 | WO2010043867A1 Pyrrolo [2, 3-d] pyrimidines as inhibitors of hsp90 |
| 04/22/2010 | WO2010043749A1 Composition for treatment of metabolic syndrome |
| 04/22/2010 | WO2010043688A1 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug |
| 04/22/2010 | WO2010043513A1 New benzimidazole derivatives |
| 04/22/2010 | WO2010043076A1 A method for constructing human placental mesenchymal cells library which is suitable for clinical application |
| 04/22/2010 | WO2010043052A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/22/2010 | WO2010043047A1 Conjugates of glp-1 agonists and uses thereof |
| 04/22/2010 | WO2010027802A9 Methods for treating diabetic wounds |
| 04/22/2010 | WO2010023572A4 Herbal extract as sensitivity enhancer toward insulin and antidiabetes |
| 04/22/2010 | WO2010014613A3 Treating various disorders using trkb agonists |
| 04/22/2010 | WO2010011922A3 Novel crystalline salts of epalrestat |
| 04/22/2010 | WO2010011879A3 Methods and compositions for treating and preventing autoimmune diseases |
| 04/22/2010 | WO2010011319A8 Magnetic heating for drug delivery and other applications |
| 04/22/2010 | WO2010008739A3 Aryl gpr119 agonists and uses thereof |
| 04/22/2010 | WO2010003624A3 Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| 04/22/2010 | WO2009143363A3 Functional metabolomics coupled microfluidic chemotaxis device and identification of novel cell mediators |
| 04/22/2010 | WO2009143065A3 Rice bran extracts and methods of use thereof |
| 04/22/2010 | WO2009071804A3 Use of phytoecdysones in the preparation of a composition for acting on metabolic syndrome |
| 04/22/2010 | WO2009068468A3 Pyridine compounds |
| 04/22/2010 | WO2009043450A8 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents |
| 04/22/2010 | WO2008047241A3 Modified corticotropin releasing factor peptides and uses thereof |
| 04/22/2010 | US20100099760 Glycyrrhetinic Acid Derivatives |
| 04/22/2010 | US20100099751 Method of treating diabetes-related vascular complications |
| 04/22/2010 | US20100099736 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |